Publications
5539 Results
- Journal / Conference
- Korean Society of Medical Oncology Meeting (September 26 to 27, 2024.Seoul, Korea)
- Year
- 2024
- Research Committee(s)
- Lung
- Study Number(s)
- S2302
Project Pragmatica: S2302 Pragmatica-Lung and its Application in rare cancers
- Journal / Conference
- New England Journal of Medicine 391:1206-1216
- Year
- 2024
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1011
Standard vs. Extended Lymphadenectomy for Muscle Invasive Bladder Cancer
- Journal / Conference
- Journal of Clinical Oncology Sep 17:JCO2400527. doi: 10.1200/JCO.24.00527. Online ahead of print
- Year
- 2024
- PMID
- PMID39288338
Correlative Science in the Cooperative Group System—Re-Engineering for Success
- Journal / Conference
- ESMO (September 13-17, 2024, Barcelona, Spain), poster
- Year
- 2024
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1216
Inherited variants in SRD5A genes and response to hormonal therapy in SWOG S1216
- Journal / Conference
- ESMO (September 13-17, 2024, Barcelona, Spain), mini-oral
- Year
- 2024
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/A031501
Alliance A031501: AMBASSADOR study of Adjuvant Pembrolizumab (Pembro) in Muscle-Invasive Urothelial Carcinoma (MIUC) vs Observation (Obs): Extended follow-up results and metastatic disease recurrence distribution
- Journal / Conference
- ASCO Quality of Care Symposium (September 27-28, 2024, San Francisco, CA), oral
- Year
- 2024
- Research Committee(s)
- Cancer Care Delivery
Development and Validation of a Risk Prediction Model for Acute Care Use among Advanced Cancer Patients on Clinical Trials
- Journal / Conference
- Lancet Haematology Sep 30:S2352-3026(24)00276-X. doi: 10.1016/S2352-3026(24)00276-X. Online ahead of print
- Year
- 2024
- Research Committee(s)
- Lymphoma
Radiation Target Nomenclature for Lymphoma Trials: Consensus Recommendations from the National Clinical Trials Network Groups
- Journal / Conference
- Blood Sep 25:blood.2024025939. doi: 10.1182/blood.2024025939. Online ahead of print
- Year
- 2024
- Research Committee(s)
- Myeloma
- PMID
- PMID39321347
- Study Number(s)
- S0777, S1211
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis
- Journal / Conference
- Haematologica Jan 1;108(1):42-47
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID35833298
- PMC
- PMC9827148
- Study Number(s)
- S0106, S1203, SWOG-8600, SWOG-9031
Improved outcomes with 7+3 induction chemotherapy for acute myeloid leukemia over the past four decades: Analysis of SWOG trial data
- Journal / Conference
- Journal of Clinical Oncology 10;41(2):336-342
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID35787017
- PMC
- PMC9839232
- Study Number(s)
- S0016, S0801